Lack of evidence for KRAS oncogenic mutations in triple-negative breast cancer

BACKGROUND: Mutational analysis of the KRAS gene has recently been established as a complementary in vitro diagnostic tool for the identification of patients with colorectal cancer who will not benefit from anti-epidermal growth factor receptor (EGFR) therapies. Assessment of the mutation status of...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Sánchez-Muñoz, Alfonso, Gallego, Elena, de Luque, Vanessa, Pérez-Rivas, Luís G, Vicioso, Luís, Ribelles, Nuria, Lozano, José, Alba, Emilio
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2010
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2868051/
https://ncbi.nlm.nih.gov/pubmed/20385028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-10-136
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg